Clinical Trials Unit

 

Conducting clinical studies that fill gaps in medical knowledge, ensuring scientific, ethical and regulatory compliance, and prioritizing the safety of participants.

 

 

 

uu

 

🏥 The Clinical Trials Unit provides various services in the area of clinical research, with a multidisciplinary technical support infrastructure and is available to support industry-initiated research projects, namely:

 

💊 Clinical Trials

🦿 Medical Device Validation Studies

🕰️ Real World Evidence (RWE) Studies

 

Feasibility and Study Submission

The Clinical Trials Unit at 2CA-Braga collaborates with industry entities in assessing the feasibility of new clinical trials, offering support, when necessary, in developing the documentation for submission to the Competent Authorities. Currently, it is recommended that promoters and CROs make this request through the CR-Digital platform, made available by 2CA-Braga.

 

For more information, please, contact us by e-mail.

 

CRDigital

Phase 1 Unit

🏢 The Clinical Academic Center of Braga (2CA-Braga) aims to conduct phase I clinical trials, including studies with biosimilar drugs and 'first in human', on healthy volunteers or those with associated pathologies, in its Clinical Trials Unit. These trials are essential for assessing the safety, dosage and preliminary efficacy of new treatments, contributing to the advancement of medical science.

 

❕To find out more, visit :

 

Phase 1 Unit

Ongoing Studies

NEPTUNUS-1
Study to assess the efficacy and safety  of ianalumab in patients with active Sjögren’s syndrome
OSE-7000
Study to evaluate the efficacy and the safety of OSE‑127 versus placebo in subjects with moderate to severe active ulcerative colitis who have failed or are intolerant to previous treatment(s)
Ocean(a) / Amgen 20180244
Study Assessing the Impact of Olpasiran on Major Cardiovascular Events in Patients with Atherosclerotic Cardiovascular Disease and Elevated Lipoprotein (a)